Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Mar-24 6:01 PM View:  | Gossamer Bio, Inc. (GOSS) | 27-Mar-24 | Sale | 23,172 | $1.16 | $26,772.90 | (< 1%) 5.18M to 5.16M | |
| 23-Jan-24 8:37 PM View: | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 24,752 | -- | -- | (100%) 24.75K to 0 | |
| 03-Jan-24 6:18 PM View: | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 9,702 | $58.75 | $569,992.00 | 64% 15.05K to 24.75K | |
| 14-Aug-23 4:41 PM View: | Mirati Therapeutics, Inc. (MRTX) | 11-Aug-23 | Private Purchase | 10,791 | $27.80 | $299,990.00 | 72% 15.05K to 25.84K | |
| 26-Jul-23 4:02 PM View: | Gossamer Bio, Inc. (GOSS) | 24-Jul-23 | Grant | 540,176 | $1.82 | $983,120.00 | 12% 4.64M to 5.18M | |
| 22-Mar-23 5:14 PM View: | Gossamer Bio, Inc. (GOSS) | 22-Mar-23 | Purchase | 440,500 | $1.14 | $503,580.00 | 10% 4.2M to 4.64M | |
| 22-Mar-23 5:14 PM View: | Gossamer Bio, Inc. (GOSS) | 21-Mar-23 | Purchase | 269,389 | $1.20 | $322,324.00 | 7% 3.93M to 4.2M | |
| 22-Mar-23 5:14 PM View: | Gossamer Bio, Inc. (GOSS) | 20-Mar-23 | Private Purchase | 168,683 | $1.03 | $174,486.00 | 4% 3.76M to 3.93M | |
| 24-Jan-23 4:17 PM View: | Mirati Therapeutics, Inc. (MRTX) | 20-Jan-23 | Grant | 6,333 | -- | -- | 73% 8.72K to 15.05K | |
| 15-Jul-22 4:21 PM View: | Gossamer Bio, Inc. (GOSS) | 15-Jul-22 | Private Purchase | 138,696 | $7.21 | $999,998.00 | 4% 3.62M to 3.76M | |
| 24-Mar-22 4:55 PM View: | Gossamer Bio, Inc. (GOSS) | 23-Mar-22 | Sale | 19,035 | $8.91 | $169,697.00 | (< 1%) 3.64M to 3.62M | |
| 18-Jan-22 8:32 PM View: | Mirati Therapeutics, Inc. (MRTX) | 14-Jan-22 | Grant | 3,619 | -- | -- | 71% 5.1K to 8.72K | |
| 01-Mar-21 7:40 PM View: | Gossamer Bio, Inc. (GOSS) | 25-Feb-21 | Grant | 162,500 | -- | -- | 5% 3.48M to 3.64M | |
| 26-Feb-21 7:00 PM View: | Nuvation Bio Inc. (NUVB) | 10-Feb-21 | Grant | 30,000 | $10.00 | $300,000.00 | 100% 0 to 30.0K | 4% |
| 26-Feb-21 7:00 PM View: | Nuvation Bio Inc. (NUVB) | 10-Feb-21 | Option Exercise | 25,000 | -- | -- | 83% 30.0K to 55.0K | |
| 20-Jan-21 6:14 PM View: | Mirati Therapeutics, Inc. (MRTX) | 15-Jan-21 | Grant | 2,098 | -- | -- | 70% 3.0K to 5.1K | |
| 14-Oct-20 7:28 PM View: | Gossamer Bio, Inc. (GOSS) | 14-Oct-20 | Market Purchase | 96,520 | $10.36 | $999,996.00 | 3% 3.38M to 3.48M | (< 1%) |
| 07-Jan-20 8:29 PM View: | Mirati Therapeutics, Inc. (MRTX) | 03-Jan-20 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 27-Sep-19 10:41 AM View: | Gossamer Bio, Inc. (GOSS) | 27-Sep-19 | Market Purchase Duplicate | 10,000 | $16.80 | $167,980.00 | < 1% 3.37M to 3.38M | (38%) |
| 03-Jun-19 4:11 PM View: | Forte Biosciences, Inc. (FBRX) | 30-May-19 | Market Purchase | 43,000 | $4.66 | $200,314.00 | 21% 202.86K to 245.86K | 9% |
| 12-Feb-19 5:25 PM View: | Gossamer Bio, Inc. (GOSS) | 12-Feb-19 | Conversion | 58,599 | -- | -- | 2% 3.31M to 3.37M | |
| 17-Sep-18 9:26 PM View: | Vital Therapies, Inc. (IMUX) | 13-Sep-18 | Market Sale | 177,443 | $0.44 | $77,678.60 | (96%) 185.44K to 8.0K | 10% |
| 15-Sep-17 4:19 PM View: | Vital Therapies, Inc. (IMUX) | 14-Sep-17 | Market Purchase | 59,200 | $4.19 | $247,870.00 | 47% 126.24K to 185.44K | (91%) |
| 21-Apr-17 5:28 PM View: | Forte Biosciences, Inc. (FBRX) | 19-Apr-17 | Acquisition (other) | 102,857 | $10.00 | $1,028,570.00 | 100% 0 to 102.86K | |
| 21-Apr-17 5:28 PM View: | Forte Biosciences, Inc. (FBRX) | 19-Apr-17 | Purchase | 100,000 | $10.00 | $1,000,000.00 | 97% 102.86K to 202.86K | |
| 15-Aug-16 9:23 AM View: | Vital Therapies, Inc. (IMUX) | 12-Aug-16 | Market Purchase | 118,243 | $5.92 | $699,999.00 | 1478% 8.0K to 126.24K | (93%) |
| 27-Aug-15 6:17 PM View: | Receptos, Inc. (RCPT) | 27-Aug-15 | Disposition | 32,500 | -- | -- | (100%) 32.5K to 0 | |
| 27-Aug-15 6:17 PM View: | Receptos, Inc. (RCPT) | 25-Aug-15 | Disposition (change in control) | 384,409 | -- | -- | (92%) 416.91K to 32.5K | |
| 03-Apr-15 9:01 PM View: | Receptos, Inc. (RCPT) | 01-Apr-15 | Grant | 32,500 | -- | -- | 8% 384.41K to 416.91K | |
| 12-Nov-14 10:00 PM View: | Receptos, Inc. (RCPT) | 11-Nov-14 | Market Sale (Planned) | 63,205 | $108.99 | $6,888,710.00 | (14%) 450.61K to 387.41K | (113%) |
| 12-Nov-14 10:00 PM View: | Receptos, Inc. (RCPT) | 10-Nov-14 | Market Sale (Planned) | 136,795 | $109.69 | $15,005,000.00 | (23%) 587.41K to 450.61K | (111%) |
| 14-May-13 5:28 PM View: | Receptos, Inc. (RCPT) | 14-May-13 | Conversion | 47,618 | $5.25 | $249,994.00 | 9% 536.79K to 584.41K | |
| 08-Mar-13 1:38 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 27,974 | -- | -- | (100%) 27.97K to 0 | |
| 03-Jan-13 6:47 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-12 | Grant | 7,230 | -- | -- | 42% 17.29K to 24.52K | |
| 02-Oct-12 9:14 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 30-Sep-12 | Grant | 32,586 | -- | -- | 31% 105.73K to 138.32K | |
| 03-Jul-12 3:38 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 02-Jul-12 | Grant | 45,789 | -- | -- | 76% 59.94K to 105.73K | |
| 04-Apr-12 3:25 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 02-Apr-12 | Grant | 59,423 | -- | -- | 11428% 0.52K to 59.94K | |
| 23-Apr-10 12:24 PM View: | Facet Biotech Corp (FACT) | 21-Apr-10 | Disposition | 102,667 | $27.00 | $2,772,010.00 | (100%) 102.67K to 0 | (< 1%) |
| 21-Apr-10 3:55 PM View: | Facet Biotech Corp (FACT) | 20-Apr-10 | Disposition (change in control) | 18,463 | $27.00 | $498,501.00 | (15%) 121.13K to 102.67K | (< 1%) |
| 05-Oct-09 2:41 PM View: | Facet Biotech Corp (FACT) | 01-Oct-09 | Payment of Exercise | 8,937 | $17.37 | $155,236.00 | (7%) 128.87K to 119.93K | (2%) |
| 10-Aug-09 4:02 PM View: | Facet Biotech Corp (FACT) | 06-Aug-09 | Grant | 27,667 | -- | -- | 28% 100.0K to 127.67K | |
| 27-Jan-09 2:00 PM View: | Facet Biotech Corp (FACT) | 23-Jan-09 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 03-Oct-08 10:56 AM View: | PDL BioPharma Inc. (PDLI) | 01-Oct-08 | Grant | 125,000 | -- | -- | 100% 0 to 125.0K | |
| 10-Jul-08 2:08 PM View: | Biogen Idec Inc. (BIIB) | 09-Jul-08 | Option Exercise | 30,175 | $45.87 | $1,384,250.00 | 94% 32.12K to 62.29K | 33% |
| 10-Jul-08 2:08 PM View: | Biogen Idec Inc. (BIIB) | 09-Jul-08 | Market Option Sale (Planned) | 30,175 | $62.07 | $1,873,070.00 | (48%) 62.29K to 32.12K | (348%) |
| 10-Jul-08 2:08 PM View: | Biogen Idec Inc. (BIIB) | 09-Jul-08 | Market Sale (Planned) | 6,662 | $62.07 | $413,534.00 | (21%) 32.12K to 25.45K | (348%) |
| 10-Apr-08 2:52 PM View: | Biogen Idec Inc. (BIIB) | 08-Apr-08 | Market Sale (Planned) | 6,425 | $64.47 | $414,208.00 | (17%) 38.54K to 32.12K | (332%) |
| 14-Feb-08 5:49 PM View: | Biogen Idec Inc. (BIIB) | 12-Feb-08 | Grant | 10,430 | -- | -- | 35% 29.43K to 39.87K | |
| 14-Feb-08 5:49 PM View: | Biogen Idec Inc. (BIIB) | 12-Feb-08 | Payment of Exercise | 1,788 | $60.56 | $108,281.00 | (4%) 39.87K to 38.08K | (360%) |
| 07-Feb-08 5:16 PM View: | Biogen Idec Inc. (BIIB) | 06-Feb-08 | Payment of Exercise | 2,017 | $60.52 | $122,069.00 | (6%) 31.45K to 29.43K | (360%) |